Dinesh Dhumal

Professional experience

OZ BIOSCIENCES, Parc Scientifique de Luminy, Zone entreprise January 2023 – Present

Formulation Scientist and LNP platform manager
Case 922 13288 Marseille Cedex 9 - FRANCE

CNRS Post-doc, CNRS, CINaM UMR 7325, Marseille, France March 2021 – February 2023
Supervisor: Dr. Ling PENG
H2020 Era-Net EuroNanoMed project “TARBRAINFEC

CNRS Post-doc, CNRS, CINaM UMR 7325, Marseille, France December 2020 – February 2021
Supervisor: Dr. Ling PENG
CNRS COVID-19 grant

CNRS Post-doc, CNRS, CINaM UMR 7325, Marseille, France December 2019 – November 2020
Supervisor: Dr. Ling PENG
H2020 Era-Net EuroNanoMed project “NANOGLIO”

CNRS Post-doc, CNRS, CINaM UMR 7325, Marseille, France April 2018 – November 2019
Supervisor: Dr. Ling PENG
H2020 Era-Net EuroNanoMed project “Target4cancer”

Education

 Ph.D. (Tech) in Pharmaceutical Chemistry (DST-Inspire Fellowship-2012), (November 2012 –

2018) Institute of
 Chemical Technology, Mumbai, Maharashtra, India.
 Master of Pharmacy in Pharmaceutical Chemistry (Gold Medal), (MHRD fellowship) ( August
2009 – June 2011) R. C. Patel Institute of Pharmaceutical Education and Research, Shirpur,
India
 Bachelor of Pharmacy (August 2005 – June 2009) North Maharashtra University, Jalgaon, India

Research Project Experience

OZ BIOSCIENCES January 2023 - Present

Formulation Scientist and LNP platform manager
 Formulation R&D: 1] Development of LNP-mRNA, LNP-siRNA, LNP-DNA formulations and their
physiochemical characterization.
 Development of Targeted LNP formulation and their physiochemical characterization.
 Screening of different in-house ionizable lipids for different nucleic acid therapeutic delivery.
 Development and evaluation of liposome for small molecule delivery.
 Protocol development, standardization and documentation of LNP catalogue and custom
services products.
  EU-HORIZON-HLTH Project: siNPAIN- Work package and team leader for development of
targeted LNP- siRNA formulation and their physiochemical characterization for the treatment
of osteoarthritis.

CNRS April 2018 – February 2023

Doctoral Researcher
 H2020- Era-Net EuroNanoMed projects: Target4cancer, NANOGLIO, TABRAINFEC,
Antineuropatho and iNanoGun, (Dr. Ling Peng group, CINaM, CNRS, Aix-Marseille University,
UMR 7325 Marseille, France) Role:
 Leading the design, synthesis and evaluation of supramolecular dendrimer nano systems.
 Elaborating bioconjugated, targeted dendrimer nano system for treating cancer and infectious
diseases.
 Nano formulations development and characterization by encapsulating siRNA or small
molecular therapeutics.
 Cooperation and project management of these European projects with partners for
experimental design and implementation, results analysis and discussion, publication and
project preparation and writing. 5] mentoring and co-supervising masters and PhD students.

Raman-Charpak Fellowship February 2017 – August

2017
Ph.D. research internship
 During PhD tenure the project “Development of ionizable lipid formulation for siRNA delivery”
got selected for prestigious Raman-Charpak fellowship in the year 2016 to carryout 6-month
research internship in France by CEFIPRA which is an Indo-French bilateral government
research organization to promote scientific research between two countries. Only 25 proposals
get selected throughout India.
 Place of internship: Dr. Ling Peng group, CINaM, CNRS UMR 7325, Aix-Marseille University,
France Role:
 Lead in development of functional ionizable lipid formulations such as liposomes and micelles
for siRNA delivery.
 Experiment designing with scientist from Dr. Peng group. 3] Weekly follow-up meeting
between home and host laboratory.
 publication writing.
 Financial management with CEFIPRA.

DST-Inspire Fellowship, November 2012 - February 2018

Ph.D.
 Dr. Dhumal was awarded with one of the most prestigious Ph.D. research fellowships, INSPIRE
from Department of Science and Technology (DST), Government of India in the year of 2012
for his Ph.D. project of “Design and synthesis of heterolysis for pharmaceutical applications”.
This fellowship is only awarded to the Ph.D. candidates who has stood first in university exams
at the Master’s level. Dr. Dhumal completed his Ph.D. under the guidance of Prof. K. G.
Akamanchi at the Institute of Chemical Technology, Mumbai, India.
 Lead in project design
 Design, development and synthesis of functional ionizable lipid excipients.
 Development and characterization of lipid based drug delivery systems such as liposomes,
micelles and nano emulsions by encapsulating small therapeutic molecules and siRNA with
their anticancer applications.
 Project management and monitoring with international collaborators.
 Publication and grant writing.
 Mentoring masters and undergraduate students.
 Yearly financial and research progress report submission to DST).

Grants And Fellowships

Year Fellowship Type Funding agency Duration Amount

Raman-Charpak PhD fellowship Indo-French Centre for the
2016 (RCF-IN-082) Research Promotion of Advanced 6 months € 10000
(Top 25 project selected throughout India). Research (IFCPAR/CEFIPRA).
ITS international travel grant Science & Engineering
2016 (ITS/3745/2016-17) Travel Research Board 1 month ₹ 30000
(Very competitive travel grant in India). (SERB), Government of
India.
CICS Travel Fellowship Indian National Science
2016 (DO/Lr. /TF-III/2016-17) Travel Academy, Government of 1 month ₹ 140000
(Very competitive travel grant in India). India.
DST-INSPIRE PhD Fellowship Department of Science and
2012 (IF-120675), (For university first Research Technology, Government of 5 Years ₹ 1900000
rank holders at master level) India
Sir Ratan Tata Trust Academic Academic
2010 scholarship-2010, (For outstanding Sir Ratan Tata, Mumbai, India 1 Year ₹ 100000
excellence
academic record)
Jr. Research Fellowship Academic Ministry of Education
2009 (Qualified national level exam GATE- 2 Year ₹ 216000
2009 to peruse Master of Pharmacy)
excellence (MHRD), Government of
India

Awards And Scientific Prizes

 Best oral presentation at MatSAN 2020, Journées Anuelles MatSan-IMBL, France.

 Best oral presentation at ICRAMC 2020, SRMIST-India and CEA-France, Chennai, India
 Biotechnology Leadership Camp (Bio-Camp) 2016, Novartis, Hyderabad, India.
 2nd Winner in BEST-INDIA 2014, by ABLE and DBT, India
 3rd Winner in International Annual Conference 2014, SACACCP, Mumbai, India
 Gold medal 1st Rank in Master of Pharmacy 2011, North Maharashtra University, India
 Qualified national level GATE 2009, IIT Roorkee, India
 1stWinner in “Research Festival AVISHKAR – 2008, NMU, Jalgaon”, India
 1stWinner in “Research Festival AVISHKAR – 2007, NMU, Jalgaon”, India

Publication Record

 Research and review article: 22

 Patent: 2 (1- Indian Patent Granted, 1- US patent applied).
 Book Chapter: 1
 Conference/workshops: Invited-6, Oral- 11, Poster-8,
 Citations: 234, H-Index: 9 (Google scholar)

Research Publications

 Galanakou C, Dhumal D, Peng L. Amphiphilic dendrimers against antibiotic resistance: light at

 the end of the tunnel? Biomater. Sci., 2023, accepted, https://doi.org/10.1039/D2BM01878K.
(Co-corresponding author)
 Dhumal D, Maron B, Malach E, Lyu Z, Ding L, Marson D, Laurini E, Ralahy B, Tintaru A, Giorgio S,
Pricl S, Hayouka Z, Peng L. Dynamic self-assembling supramolecular dendrimers as potent
antibacterial candidates against drug-resistant bacteria and biofilm, Nanoscale, 2022, 14,
9286-9296 https://doi.org/10.1039/D2NR02305A.
 Dhumal D, Patil M, Kulkarni R, Akamanchi KG, Development and evaluation of amphiphilic
heterolipid based pH-sensitive nanomicelles of doxorubicin, J Drug Deliv Sci Technol, 2022,
68103079. https://doi.org/10.1016/j.jddst.2021.103079
 Zhang W, Dhumal D, Zhu X, Ralahy B, Ellert-Miklaszewska A, Wu J, Laurini E, Yao Y, Kao C,
Iovanna JL, Pricl S, Kaminska B, Xia Y, Peng L. Bola-Amphiphilic Glycodendrimers: New
Carbohydrate Mimicking Scaffolds to Target Carbohydrate-Binding Proteins, Chem. Eur. J.
2022, e202201 https://doi.org/10.1002/chem.202201400.
 Cong M, Xu G, Yang S, Zhang J, Zhang W, Dhumal D, Laurini E, Zhang K, Xia Y, Pricl S, Peng L,
Zhao W. A self-assembling prodrug nanosystem to enhance metabolic stability and anticancer
activity of gemcitabine, Chin. Chem. Lett. 2022, 33 (5), 2481-2485,
(https://doi.org/10.1016/j.cclet.2021.11.083)
 Dhumal D, Lan W, Ding L, Jiang Y, Lyu Z, Laurini E, Marson D, Tintaru A, Dusetti N, Giorgio S,
Iovanna J, Pricl S, Peng L. An ionizable supramolecular dendrimer nanosystem for effective
siRNA delivery with a favorable safety profile, Nano Res, 2021, 14, 2247–2254.
https://doi.org/10.1007/s12274-020-3216-8.
 Dhumal D, Patil P, Kulkarni R, Akamanchi KG. Experimentally validated QSAR model for surface
pKa prediction of heterolipid having potential as delivery materials for nucleic acid
therapeutics, ACS Omega, 2020, 5, 49, 32023–32031.
https://doi.org/10.1021/acsomega.0c04931.
 Ganorkar S, Heyden Y. V, Shirkhedkar A, Lokwani D, Dhumal D, Bobade P. Pharmaceutical
analysis combined with in-silico therapeutic and toxicological profiling on zileuton and its
impurities to assist in modern drug discovery, J. Pharm. Biomed. Anal 2020, 179, 112982.
https://doi.org/10.1016/j.jpba.2019.112982.
 Mbuso F, Kalhapure R, Dhumal D, Agrawal N, Andeve C, Akamanchi KG, Govender T,
Antimicrobial cell penetrating peptides with bacterial cell specificity: pharmacophore
modelling, quantitative structure activity relationship and molecular dynamics simulation, J.
Biomol. Struct. Dyn., 2019, 37, 9, 2370-2380. https://doi.org/10.1080/07391102.2018.1484814
 Dhumal D, Akamanchi KG, Self-microemulsifying drug delivery system for camptothecin using
new bicephalous heterolipid with tertiary-amine as branching element, Int. J. Pharm., 2018,
541, 48-55. https://doi.org/10.1016/j.ijpharm.2018.02.030.
 Ding L, Lyu Z, Dhumal D, Kao C, Bernard M, Peng L, Dendrimer-based magnetic resonance
imaging agents for brain cancer, Sci. China Mat., 2018, 61, 1420–1443.
https://doi.org/10.1007/s40843-018-9323-6.
 Ganorkar S, Dhumal D, Shirkhedkar A. Development and validation of simple RP-HPLC-PDA
analytical protocol for zileuton assisted with Design of Experiments for robustness
determination. Arab. J. Chem. 2017,10, 273-82. https://doi.org/10.1016/j.arabjc.2014.03.009.
 Dhumal D, Ganorkar S, Patil U, Singh D, Sharma M, Bhadoriya KS, RP-HPLC-PDA Analyses of
Tapentadol: Application of Experimental Design, Anal. Chem. lett., 2016, 6, 214-223.
https://doi.org/10.1080/22297928.2015.1068705.
 Bhadoriya KS, Kumawat NK, Bhavthankar SV, Avchar MH, Dhumal DM, Patil SD, Jain SV.
Exploring 2D and 3D QSARs of benzimidazole derivatives as transient receptor potential
melastatin 8 (TRPM8) antagonists using MLR and kNN-MFA methodology. J. Saudi Chem. Soc.
 2016, 1, S256-70. https://doi.org/10.1016/j.jscs.2012.11.001.
 Dhumal D, Kothari P, Kalhapure R, Akamanchi KG, Self-microemulsifying drug delivery system
of curcumin with enhanced solubility and bioavailability using a new semi-synthetic
bicephalous heterolipid: in vitro and in vivo evaluation, RSC Adv., 2015, 5, 90295-90306. DOI
https://doi.org/10.1039/C5RA18112G.
 Pandey R, Patil P, Bari S, Dhumal D. Simultaneous estimation of etodolac and thiocolchicoside
in bulk and in tablet formulation by UV-spectrophotometry. Chem. Ind. Chem. Eng. 2014, 20,
9-17. https://doi.org/10.2298/CICEQ120114098P.
 Ganorkar S, Dhumal D, Shirkhedkar A. Application of UV-spectrophotometry for determination
of zileuton in bulk and in tablets. Indian Drugs. 2013, 50, 40-44.
https://doi.org/10.53879/id.50.06.p0040.
 Dhumal D, Shirkhedkar A, Nerkar P, Surana S. Simultaneous estimation of moxifloxacin
hydrochloride and dexamethasone sodium phosphate in bulk and in ophthalmic solution by
RP-HPLC. J. Chil. Chem. Soc., 2012, 57, 1344-7. http://dx.doi.org/10.4067/S0717-
97072012000400003.
 Shirkhedkar A, Dhumal D, Surana S, A Sensitive and Specific High-Performance Thin-Layer
Chromatography - Densitometry Method for Determination of Rebamipide in the Bulk Material
and in Pharmaceutical Formulation. JPC-J Planar Chromat., 2012, 25, 368-73.
 https://doi.org/10.1556/JPC.25.2012.4.17.
 Mutha R, Dhumal D, Patil P, Shirkhedkar A, Bari S. Quantitative determination of raloxifene
hydrochloride in bulk and tablet formulation by UV-spectrophotometry and first order
derivative using area under curve method, Indian Drugs. 2012, 49:40-43.
https://doi.org/10.53879/id.49.09.p0040.
 Dhumal D, Shirkhedkar A, Surana S. Quantitative determination of moxifloxacin hydrochloride
in bulk and ophthalmic solution by UV-spectrophotometry and first order derivative using area
under curve. Der Pharm. Lett. 2011, 3, 453-456.
 Dhumal D, Shirkhedkar A, Surana S, Quantitative determination of rebamipide in bulk and
tablet formulation by UV-spectrophotometry and first order derivative using area under curve
method, Indian Drugs, 2011, 48, 50- 53.

Patents

 Peng L, Hayouka Z, Dhumal D, Cohen E, Lyu Z, Bar M. Self-assembling dendrimers and

antibacterial uses thereof, US patent application date: May 17, 2022; Application N°:
63/63/214,271. Applicant: The Hebrew University of Jerusalem and CNRS; Filing country:
Israel.
 Dhumal D, Akamanchi KG. Amphipathic Heterolipids As Pharmaceutical Excipients, 2020,
Indian Patent, Granted No: 345590. Applicant: Institute of Chemical Technology, Mumbai,
Filing country: India.

Book Chapter

 Lyu Z, Ding L, Dhumal D, Huang Y-T, Kao C-L, Peng L. “Poly(amidoamine) (PAMAM) dendrimers:
synthesis and biological applications” in Dendrimer Chemistry: Synthetic Approaches Towards
Complex Architectures, Eds: Michal Malkoch, Sandra García Gallego, The Royal Society of
Chemistry, 2020; 85 - 113.

Conferences/Workshops
 Amphiphilic dendrimers for biomedical applications, “Workshop and training programme:
Formulation Development Aspects of Nanotechnology Based Drug Delivery Systems” DST
STUTI in association with Institute of Chemical Technology, Mumbai, R. C. Patel Institute of
Pharmaceutical Education and Research, Shirpur, India. August 2022.
 Nanomedicine approach to combat COVID-19 pandemic, “Gujcost sponsored-DST online
seminar”, Gujarat Technological University, Smt B.N.B Swaminarayan Pharmacy College, Vapi,
India. March 2022.
 Scientific Research Paper, Patents and Research Proposal Writing for Grants and an Ethics,
“One-Week (online) Short Term Training Program”, AICTE, New Delhi and R. C. Patel Institute
of Pharmaceutical Education and Research, Shirpur, India. June 2021.
 Nanomedicine approach to combat COVID-19 pandemic, “International e – Conference Covid -
19 era - Need & Challenges in Healthcare & Pharma Sector”, Dayanand Institute of Pharmacy,
Latur, India, Sponsored by SRTMU, Nanded, APTI & IPA, June 2021.
 Amphiphilic dendrimers for biomedical applications, “International e-Faculty/staff
development program”, Indian Pharmaceutical Association and Sir Dr. M. S. Gosavi College of
Pharmaceutical Education and Research, Nasik, India. September 2020.
 Amphiphilic dendrimers and its biomedical applications, “International Webinar”, H. R. Patel
Institute of Pharmaceutical Education and Research, Shirpur, India. July 2020.

ORAL Presentations

 Dhumal D, Maron B, Malach E, Lyu Z, Ding L, Marson D, Laurini E, Ralahy B, Tintaru A, Giorgio S,
Pricl S, Hayouka Z, Peng L. Dynamic self-assembling supramolecular dendrimers as potent
antibacterial candidates against drug-resistant bacteria and biofilm. “Journées Franco-
Italiennes de Chimie (JFIC2022)”, Toulon, France, April 2022
 Dhumal D, Maron B, Malach E, Lyu Z, Ding L, Marson D, Laurini E, Giorgio S, Pricl S, Hayouka Z,
Peng L. Self-assembling supramolecular dendrimers as potent antibacterial candidates against
drug-resistant bacteria and biofilm, “SFNano 7th Annual Meeting 2021”, December 2021,
Angers, France.
 Dhumal D, Maron B, Malach E, Lyu Z, Ding L, Marson D, Laurini E, Giorgio S, Pricl S, Hayouka Z,
Peng L. Self-assembling supramolecular dendrimers as potent antibacterial candidates against
drug-resistant bacteria and biofilm, “Journée du laboratoire: CINaM 2021”, October 2021,
Cassis, France.
 Dhumal D, Maron B, Malach E, Lyu Z, Ding L, Marson D, Laurini E, Giorgio S, Pricl S, Hayouka Z,
Peng L. Self-assembling supramolecular dendrimers as potent antibacterial candidates against
drug-resistant bacteria and biofilm, “Ist Drug Delivery in Microbial Cells (DDMiC)” September-
October 2021, Porto, Portugal.
 Dhumal D, Lan W, Ding L, Jiang Y, Lyu Z, Laurini E, Marson D, Tintaru A, Dusetti N, Giorgio S,
Iovanna J, Pricl S, Peng L. An ionizable supramolecular dendrimer nanosystem for effective
siRNA delivery with a favorable toxicity profile, “28th Young Research Fellows Meeting
Journées Jeunes Chercheurs”, Faculty of Pharmacy, University of Paris, Paris, France (webinar),
February 2021.
 Dhumal D, Lan W, Ding L, Jiang Y, Lyu Z, Laurini E, Marson D, Tintaru A, Dusetti N, Giorgio S,
Iovanna J, Pricl S, Peng L. An ionizable supramolecular dendrimer nanosystem for effective
siRNA delivery with a favorable toxicity profile, “6th and 20th Journées Annuelles MATSAN et
IMBL”, Lyon, France (webinar), October 2020. (Best oral presentation)
 Dhumal D, Ding L, Lan W, Lyu Z, Iovanna J, Peng L. Ionizable Amphiphilic Dendrimers for
Biomedical Applications, “4th International Conference on Recent Advances in Material
 Chemistry (ICRAMC-2020)”, SRM Institute of Science and Technology with CEA-Paris, Chennai,
India, February 2020. (Best oral presentation)
 Dhumal D, Jiang Y, Lan W, Ding L, Lyu Z, Iovanna J, Peng L. Supramolecular dendrimers for
biomedical applications, “Workshop 2: Emergent Technologies to Deliver Antibacterials into
Biofilms”, organized by the H2020 DelNAM project and University of Ghent, Belgium,
November 2019.
 Dhumal D, Mathew S, Athavale S, Shakeel T, Nair V, Girdhar A, Dodeja A. ZEPHYR INHALER
(Team #7 Novartis Case Study), “Biotechnology Leadership Camp (Bio-Camp) 2016”, Novartis,
Hyderabad, India, July 2016.
 Dhumal D, Kale S, Jain A, Wagh G, Veer S. LIPIsols-designer dendritic heterolipids for nano
based products (Team #4 BEST Entrepreneurship Programme), “BEST INDIA 2014” Association
of Biotechnology Led Enterprises and Department of Biotechnology Indian Government,
Bangalore, India, October 2014. (2nd winner of competition)
 Dhumal D, More D, Chavan R, Bari M. Guar gum blended alginate hydrogel beads for enzyme
entrapment, “Research Festival AVISHKAR-2007”, North Maharashtra University, Jalgaon,
India, December 2007. (1st winner of competition).

Poster Presentation

 Faya M, Kalhapure R, Dhumal D, Agrawal N, Omolo C, Akamanchi K, Govender T. Antimicrobial

cell penetrating peptides with bacterial cell specificity: Pharmacophore modelling, Quantitative
Structure Activity Relationship and Molecular Dynamics Simulation, “Nano Africa”, Durban,
South Africa, April 2018.
 Dhumal D, Kothari P, Kalhapure R, Akamanchi K. Design and Synthesis of Heterolipid E1E for
Pharmaceutical Applications, “25th Chemistry PACA day”, Marseille, France, April 2017.
 Dhumal D, Akamanchi K. Dendritic Heterolipid Encapsulated Camptothecin in Self-
microemulsifying System with Enhanced Solubility and Anticancer Activity: In-vitro and In-silico
Evaluation, “The 2016 Symposium on Biomaterials Science”, New Jersey, USA. October 2016.
 Dhumal D, Kale S, Jain A, Wagh G, Veer S. LIPIsols-designer dendritic heterolipids for nano
based products, “International Knowledge Millennium Conference”, Hyderabad, India,
November 2014.
 Dhumal D, Akamanchi K. Development of novel oleic acid based heterolipid E1E and its
application for nanomedicine, “International Annual Conference on Clinical Pharmacology-
Translational Research: Patient to Public Health”, Mumbai, India, April, 2014. (3rd prize in
poster competition)
 Dhumal D, Shirkhedkar A, “Simultaneous estimation of moxifloxacin hydrochloride and
dexamethasone sodium phosphate in bulk and in eye drops by UV-Spectrophotometry”,
“Research Festival AVISHKAR- 2010”, North Maharashtra University, Jalgaon, India, December
2010.
 Dhumal D, More D, Chavan R, Bari M. Design and Development of Starch-Urea-Stearate
Phthalate Complex
 A pH Sensitive Intelligent Drug Delivery System, “The 3rd Young Pharmacists Innovative Project
Award – 2009”, Mumbai, India, December 2009.
 Dhumal D, More D, Chavan R, Bari M. “Preparation and Evaluation of Starch-Urea-Stearate
Complex as a Controlled Release Polymer”, “Research Festival AVISHKAR-2008” North
Maharashtra University, Jalgaon, India, December 2008. (1st prize in poster competition)

Reviewer Of The Scientific Proposal Evaluation

 National Science Centre, Poland

Reviewer Of The Scientific Journals

 Cell Reports Physical Science

 ACS Biomaterials Science & Engineering
 Acta Biomaterial
 Nanomedicine
 Critical Reviews in Analytical Chemistry
 Toxicology Research

Memberships of Societies

 Société de Chimie Thérapeutique, France

 Société Française de Nanomédecine, France
 Société Française de Métallurgie et de Matériaux, France
 UDCT Alumni Association, India

Teaching And Supervision Experience

 During Ph.D. and Post-doctoral tenure as mentoring and co-supervision activities

Master students:
 Mr. Raheem Daniel, University Bourgogne France - Comté, France, 1 May 2021 – 30 June 2021.
 Ms. Galanakou Christina, National and Kapodistrian University of Athens, Greece, 01 February
2022 – 29 July 2022 and 17 February 2020 – 17 July 2020. (Co-author manuscript under
preparation).
 Ms. Zerva Eleni, National and Kapodistrian University of Athens, Greece, 17 February 2020-17
July 2020.
 Mr. Lepelletier Timothée, Ecole Nationale Supérieure de Chimie de Lille, France, 07 June 2019
–30 August 2019.
 Mr. Patil Pankaj, Institute of Chemical Technology, Mumbai, India, (1 August 2013 - 30 June
2014). Co-author in one publication
 Ms. Kothari Priya, Institute of Chemical Technology, Mumbai, India, (1 January 2013 – 30 June
2013). Co-author in one publication
PhD student:
 Ms. Liu Xi, Aix-Marseille Université, France, 1 November 2020 - 1 November 2024 (Co-author
manuscript under preparation).
 Before Ph.D. as assistant professor to teach undergraduate students
 Assistant Professor, R. C. Patel Institute of Pharmaceutical Education and Research (Shirpur),
North Maharashtra University, Jalgaon, Maharashtra, India. July 2011 – October 2012
 Teaching responsibilities: Teaching and laboratory practical’s for B. Pharmacy and B. Tech
cosmetics 1st year students, Subjects: Inorganic chemistry, Biochemistry and Analytical
chemistry.

Conference And Workshop Organization

 Symposium on self-assembly and supramolecular chemistry, Centre Interdisciplinarian de

Nanoscience de Marseille, Aix-Marseille University, Marseille, France, June 14,2019. (Co-
organiser)
 Symposium on nanomedicine for treating cancer and brain diseases, Centre Interdisciplinarian
de Nanoscience de Marseille, Aix-Marseille University, Marseille, France, March 8, 2019. (Co-
organiser)
 International Workshop on Research Writing Skills - Publish or Perish, Institute of Chemical
Technology, Mumbai India, November 2012 - 2013, 2014. (Part of malmanagement team)
 Regulatory Roadmap for Pharmaceuticals in Global Market under the aegis of TEQIUP
delegate, Institute of Chemical Technology, Mumbai, India, November 29, 2012. (Part of
malmanagement team)

Skills

 Functional biomaterial synthesis: Ionizable lipids and Amphiphilic dendrimers

 Coupling conjugation of biomolecules: Peptides, Sugar (Glucose/mannose) and Nanobody
conjugation via different click chemistry
 Formulation and development: LNP, Micelles, Liposomes, Nano emulsions, Nanogels and solid
dosage forms
 Characterization: NMR, HRMS, HPLC, UV, IR, Fluorescence spectrometer, DLS, Zettaliter, gel
electrophoresis, colorimetric, pKa determination (TNS assay, NMR, pH back-titration, Zeta), Rib
green assay.
 Computational modelling: Development of 2D and 3D QSAR model, molecular simulation
dynamics, Docking studies and analysis.
 Cell culture: Basic knowledge of cell culture with training and use of confocal microscope
 Mentoring and monitoring: Undergraduate and Master’s students
 Project management: Writing scientific project, research articles, project follow up with
collaborators, designing and troubleshooting of experiments.